SciCombinator

Discover the most talked about and latest scientific content & concepts.

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger, G Averous, P Bachellier and IJ Namer
Abstract
Pancreatic adenocarcinomas (PAs) have very poor prognoses even when surgery is possible. Currently, there are no tissular biomarkers to predict long-term survival in patients with PA. The aims of this study were to (1) describe the metabolome of pancreatic parenchyma (PP) and PA, (2) determine the impact of neoadjuvant chemotherapy on PP and PA, and (3) find tissue metabolic biomarkers associated with long-term survivors, using metabolomics analysis.
Tweets*
3
Facebook likes*
0
Reddit*
0
News coverage*
55
Blogs*
0
SC clicks
1
Concepts
Pancreatic cancer, Antimetabolite, Digestion, Adenocarcinoma, Enzyme, Metabolome, Metabolomics, Metabolism
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com